Moadab, Fatemeh
Wang, Xiaoxing
Le, Ethan
Gazitt, Tal
Najjar, Rayan
Nelson, J. Lee
Joshua, Vijay
Malmström, Vivianne
Elkon, Keith
Grönwall, Caroline
Mustelin, Tomas
Funding for this research was provided by:
National Institutes of Health (K08 AR082939, R21 AR075134, R01 AR074939, R01 AR081654)
Article History
Received: 12 March 2024
Accepted: 2 July 2024
First Online: 5 July 2024
Competing interests
: TM reports consulting fees from Cugene, Miro Bio, ROME Therapeutics, Evolved, and Codify Therapeutics. All other authors declare no competing interests.